Worldwide inverse association between gastric cancer and esophageal adenocarcinoma suggesting a common environmental factor exerting opposing effects

American Journal of Gastroenterology

Volumn 111, Issue 2, 2016, Pages 228-239

  Derakhshan, Mohammad H ^a   Arnold, Melina ^b   Brewster, David H ^c   Going, James J ^a   Mitchell, David R ^a   Forman, David ^b   McColl, Kenneth E L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH CANCER; ADENOCARCINOMA; AGE; AGED; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; ESOPHAGEAL NEOPLASMS; HEALTH; HELICOBACTER INFECTIONS; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STOMACH NEOPLASMS;

ADENOCARCINOMA; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; ESOPHAGEAL NEOPLASMS; FEMALE; GLOBAL HEALTH; HELICOBACTER INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS;

EID: 84954348409     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.405     Document Type: Article

References (36)

1. Ferlay J, Bray F, Steliarova-Foucher E, et al. Cancer Incidence in Five Continents, CI5plus: IARC CancerBase No. 9 [Internet] International Agency for Research on Cancer: Lyon, France, 2014, Available from http://ci5.iarc.fr
2. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9
3. Kong CY, Nattinger KJ, Hayeck TJ, et al. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev 2011; 20: 2450-6
4. Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 2014; 109: 336-43
5. Drahos J, Xiao Q, Risch HA, et al. Age-specifi c risk factor profi les of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium. Int J Cancer. 2016; 138: 55-64
6. WHO. WHO global report on trends in prevalence of tobacco smoking 2015. Online report; NLM classifi cation WM 290. Available at apps.who.int. (accessed on 16 October 2015
7. Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res 2008; 1: 308-11
8. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal infl ammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008; 57: 734-9
9. Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003; 18: 279-89
10. De Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005; 191: 761-7
11. McColl KEL, Watabe H, Derakhshan MH. Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2008; 57: 721-3
12. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007; 56: 918-25
13. Gajperia C, Barbiere JM, Greenberg D, et al. Recent incidence trends and sociodemographic features of oesophageal and gastric cancer types in an English region. Aliment Pharmacol Ther 2009; 30: 873-80
14. Forman D, Bray F, Brewster DH, et al. Cancer incidence in Five Continents Vol X (electronic version): IARC: Lyon, 2013, http://ci5.iarc.fr
15. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 Lyon, France, International Agency for Research on Cancer: 2013
16. Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2014; 64: 381-7
17. Colquhoun A, Arnold M, Ferlay J, et al. Global patterns of cardia and noncardia gastric cancer incidence in 2012. Gut 2015; 64: 1881-8
18. Fritz A, Percy C, Jack A, et al. International Classifi cation of Diseases for Oncology, 3rd edn, First Revision World Health Organization: Geneva, Switzerland, 2013
19. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents Vol IX: International Agency for Research on Cancer: Lyon, France, 2007
20. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51
21. Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol 2002; 14 : 107-13
22. Ekstrom AM, Signorello LB, Hansson LE, et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999; 91: 786-90
23. Sonnenberg A. Historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther 2013; 38: 329-42
24. Lee YY, Derakhshan MH. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med 2013; 16: 358-65
25. Peleteiro B, Castro C, Morais S, et al. Worldwide burden of gastric cancer attributable to tobacco smoking in 2012 and predictions for 2020. Dig Dis Sci 2015; 60: 2470-6
26. Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, et al. Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study aft er a longer follow-up. Int J Cancer 2012; 131: 2910-9
27. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005; 96: 1-6
28. Kubo A, Corley DA. Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol 2007; 102: 2323-30
29. Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 2015; 136 : 487-90
30. Kamada T, Haruma K, Ito M, et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter 2015 ; 20: 192-8
31. Feldman M, Cryer B, McArthur KE, et al. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 1996; 110: 1043-52
32. Miendje Deyi VY, Vanderpas J, Bontems P, et al. Marching cohort of Helicobacter pylori infection over two decades (1988-2007): combined Effects of secular trend and population migration. Epidemiol Infect 2011; 139: 572-80
33. Inoue M, Tajima K, Kobayashi S, et al. Protective factor against progression from atrophic gastritis to gastric cancer-data from a cohort study in Japan. Int J Cancer 1996; 66: 309-14
34. Peitz U, Wex T, Vieth M, et al. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. J Gastroenterol Hepatol 2011; 26: 82-9
35. Derakhshan MH, El-Omar E, Oien K, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 2006: 1293-9
36. Meining A, Kompisch A, Stolte M. Comparative classifi cation and grading of Helicobacter pylori gastritis in patients with gastric cancer and patients with functional dyspepsia. Scand J Gastroenterol 2003; 38: 707-11